Biopharmaceutical company Ablynx has deployed IDBS’ E-WorkBook Suite to manage data associated with the discovery and development of Nanobodies, a new class of antibody-derived therapeutic proteins for the treatment of major disease areas including inflammation, thrombosis, oncology and pulmonary disease. E-WorkBook Suite is a data management solution designed to simplify workflows and protect Intellectual Property (IP) assets. It offers a compliant environment, enabling scientists to capture, analyse and share data in a single, secure environment. Dominique Vlieghe, senior bioinformatician at Ablynx commented: ‘In E-WorkBook we believe we have found a complete solution that will support both rigid and flexible workflows. E-WorkBook contains native functionality suited to our requirements.’
Media Partners